JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$3.58B |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$2.7B |
| 3 |
Apple
AAPL
|
+$1.71B |
| 4 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.57B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.51B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$920M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$817M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$794M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.61% |
| 2 | Financials | 11.06% |
| 3 | Consumer Discretionary | 9.77% |
| 4 | Healthcare | 9.57% |
| 5 | Industrials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GLS
4551
DELISTED
Gelesis Holdings, Inc.
GLS
| $476K | ﹤0.01% |
48,662
| – | – |
|
4552
PUT
Antero Resources
AR
$11.3B
| $475K | ﹤0.01% |
31,600
-10,900
| -26% | -$128K |
|
4553
Citizens & Northern Corp
CZNC
$466M
| $474K | ﹤0.01% |
19,361
-33,748
| -64% | -$829K |
|
4554
Root
ROOT
$772M
| $472K | ﹤0.01% |
2,427
+357
| +17% | +$67.5K |
|
4555
Ceragon Networks
CRNT
$198M
| $471K | ﹤0.01% |
125,031
-95,999
| -43% | -$340K |
|
4556
Ocular Therapeutix
OCUL
$2.22B
| $471K | ﹤0.01% |
33,199
-7,105
| -18% | -$108K |
|
|
AD
4557
Array Digital Infrastructure
AD
$3.09B
| $471K | ﹤0.01% |
12,968
-25,651
| -66% | -$953K |
|
4558
Aclaris Therapeutics
ACRS
$863M
| $470K | ﹤0.01% |
26,777
+26,756
| +127,410% | +$608K |
|
|
AERI
4559
DELISTED
Aerie Pharmaceuticals
AERI
| $470K | ﹤0.01% |
29,400
+5,126
| +21% | +$87.9K |
|
|
ODT
4560
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $470K | ﹤0.01% |
134,633
+60,484
| +82% | +$208K |
|
4561
Criteo S.A. Ordinary Shares
CRTO
$915M
| $469K | ﹤0.01% |
10,383
-143,575
| -93% | -$5.53M |
|
4562
Ericsson
ERIC
$33.6B
| $468K | ﹤0.01% |
37,174
+484
| +1% | +$6.48K |
|
4563
Arq
ARQ
$99.6M
| $467K | ﹤0.01% |
63,054
+12,978
| +26% | +$80K |
|
4564
PUT
Ocugen
OCGN
$458M
| $466K | ﹤0.01% |
+58,000
| New | +$489K |
|
|
TLIS
4565
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
| $466K | ﹤0.01% |
2,815
-7,764
| -73% | -$1.32M |
|
|
DENN
4566
DELISTED
Denny's
DENN
| $465K | ﹤0.01% |
28,198
-74,829
| -73% | -$1.31M |
|
4567
1stdibs.com
DIBS
$163M
| $465K | ﹤0.01% |
+13,345
| New | +$343K |
|
|
SLY
4568
DELISTED
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
| $465K | ﹤0.01% |
4,757
+210
| +5% | +$20.3K |
|
4569
iShares Dow Jones US ETF
IYY
$3.09B
| $464K | ﹤0.01% |
4,294
+1,488
| +53% | +$156K |
|
|
SIEN
4570
DELISTED
Sientra, Inc.
SIEN
| $464K | ﹤0.01% |
5,819
-5,659
| -49% | -$402K |
|
4571
Amplify Alternative Harvest ETF
MJ
$112M
| $463K | ﹤0.01% |
1,876
-42
| -2% | -$10.6K |
|
4572
Stoke Therapeutics
STOK
$2.02B
| $463K | ﹤0.01% |
13,745
+4,156
| +43% | +$147K |
|
4573
Vanguard S&P Mid-Cap 400 Value ETF
IVOV
$1.38B
| $462K | ﹤0.01% |
5,704
| – | – |
|
|
SCVX
4574
DELISTED
SCVX Corp.
SCVX
| $462K | ﹤0.01% |
46,688
-289,487
| -86% | -$2.87M |
|
|
STFC
4575
DELISTED
State Auto Financial Corp
STFC
| $462K | ﹤0.01% |
26,994
-31,168
| -54% | -$583K |
|
Similar funds
JP Morgan Chase's Q2 2021 Portfolio in Review
As of Q2 2021, JP Morgan Chase held 6,872 positions worth $838B, up 12% from $749B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase deployed $36.2B of net new capital in Q2 2021, opening 694 new positions and adding to 2,351 existing holdings. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $1.51B trimmed.
- JP Morgan Chase's largest Q2 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2021, an estimated $3.58B increase.
- JP Morgan Chase's biggest Q2 2021 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.51B.
- JP Morgan Chase fully exited INPHI CORPORATION in Q2 2021, selling an estimated $333M.
- JP Morgan Chase's ten largest holdings make up 16% of its $838B portfolio in Q2 2021.
- JP Morgan Chase opened 694 new positions and closed 449 in Q2 2021.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $838B.
Based on JP Morgan Chase's 13F filing for Q2 2021, filed 12 Aug 2021.